PRESOL | A | to participate in a study to characterize the safety of recombinant protective antigen in a vaccine for anthrax, and shall measure serum antibody levels induced by the protective antigen.

FBO DAILY ISSUE OF SEPTEMBER 18, 2005 FBO #1392
SOLICITATION NOTICE

A -- to participate in a study to characterize the safety of recombinant protective antigen in a vaccine for anthrax, and shall measure serum antibody levels induced by the protective antigen.

Notice Date: 9/16/2005
Notice Type: Solicitation Notice
NAICS: 541380 — Testing Laboratories
Contracting Office: Department of Health and Human Services, National Institutes of Health, Office of Administration, 6011 Executive Blvd, Rm 538, Rockville, MD, 20892-7663
ZIP Code: 20892-7663
Solicitation Number: 263-2005P(DQ)0154
Response Due: 9/23/2005
Archive Date: 9/23/2005
Description: The contractor shall participate in a study to characterize the safety of recombinant protective antigen in a vaccine for anthrax, and shall measure serum antibody levels induced by the protective antigen. The National Institutes of Health intends to procure on a firm, fixed price, sole source basis in accordance with FAR 6.302-1 as authorized by 41 U.S.C. 253-C (1), The above
Place of Performance: Address: The National Institutes of Health, Bldg 6, Room 1A05, 9000 Rockville Pike, Bethesda, MD 20892; Country: USA
Record: SN00897027-W 20050918/050916211745 (fbodaily.com)
Source: FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's FBO Daily Index Page |